Earnings
NMTR
1.390
-2.80%
-0.040
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
37.85M
--
--
--
--
--
0.00
--
--
--
1.00M
75.00K
38.93M
225.96K
--
--
--
--
--
--
5580.00
231.53K
39.16M
--
1.49M
14.22K
--
--
--
--
--
5.34M
--
--
--
7000.00
6.85M
0.00
--
--
--
167.94K
167.94K
7.02M
20.46K
164.18M
-132.06M
--
--
--
32.14M
32.14M
39.16M
FY 2019-12-31
4.59M
--
--
--
--
--
0.00
--
--
--
555.05K
75.00K
5.22M
68.25K
--
--
--
--
--
--
5580.00
73.84K
5.30M
--
3.89M
3.18M
--
--
--
--
--
4.79M
--
--
--
3.05M
14.91M
0.00
--
--
--
--
0.00
14.91M
3950.00
60.95M
-70.56M
--
--
--
-9.61M
-9.61M
5.30M
FY 2018-12-31
5.73M
75.00K
--
--
--
--
0.00
--
--
--
504.91K
179.71K
6.41M
35.10K
--
--
--
--
--
--
5580.00
40.68K
6.45M
--
3.62M
5.20M
--
--
--
--
--
927.95K
--
--
--
370.00K
10.11M
0.00
--
--
--
--
0.00
10.11M
2610.00
39.85M
-43.52M
--
--
--
-3.66M
-3.66M
6.45M
FY 2017-12-31
426.00K
--
--
90.00K
--
--
0.00
--
101.00K
--
46.00K
--
663.00K
--
--
--
--
--
0.00
--
14.00K
14.00K
677.00K
--
441.00K
1.36M
--
--
--
--
--
692.00K
--
--
--
158.00K
2.65M
0.00
--
--
--
--
0.00
2.65M
1000.00
38.04M
-40.01M
--
--
--
-1.97M
-1.97M
677.00K
FY 2016-12-31
1.45M
--
--
856.00K
--
--
0.00
--
1.10M
--
619.00K
--
4.03M
--
--
--
--
--
2.42M
--
14.00K
2.43M
6.46M
--
268.00K
38.00K
--
--
--
--
--
1.79M
--
--
--
1.88M
3.98M
0.00
--
--
--
--
0.00
3.98M
1000.00
34.58M
-32.09M
--
--
--
2.49M
2.49M
6.46M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NMTR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze 9 Meters Biopharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.